{"hands_on_practices": [{"introduction": "The efficacy of a therapeutic monoclonal antibody begins with its most fundamental function: binding to its molecular target. This exercise grounds your understanding in the quantitative relationship between an antibody's intrinsic binding affinity, its concentration at the site of action, and the resulting level of target engagement. By deriving the classic receptor occupancy equation and applying it to a practical scenario of affinity maturation, you will develop a core intuition for how molecular engineering enhancements translate directly into improved pharmacodynamic outcomes. [@problem_id:2900130]", "problem": "A biotechnology team is optimizing a therapeutic monoclonal antibody (mAb) that binds a cell-surface receptor in solid tumor interstitial fluid. At equilibrium, binding between free ligand (the mAb) of concentration $[L]$ and unoccupied receptor $R$ forms the complex $RL$ according to the reversible reaction $R + L \\rightleftharpoons RL$. The equilibrium dissociation constant is defined by $K_{D} = \\dfrac{[R][L]}{[RL]}$. The receptor occupancy is defined as the fraction of total receptors bound by ligand, $\\theta = \\dfrac{[RL]}{R_{T}}$, where $R_{T} = [R] + [RL]$.\n\nAssume the following conditions hold: (i) binding is monovalent and noncooperative; (ii) the free ligand concentration $[L]$ is not appreciably depleted by binding because $[L] \\gg R_{T}$, so that $[L]$ can be treated as a constant with respect to receptor binding; and (iii) the system is at equilibrium.\n\nStarting only from these definitions and assumptions, first derive an expression for $\\theta$ in terms of $[L]$ and $K_{D}$. Then apply it to the following scenario. In a dosing regimen that produces a steady interstitial free mAb concentration of $[L] = 3.00\\,\\mathrm{nM}$, a parental mAb has $K_{D,\\mathrm{par}} = 30.0\\,\\mathrm{nM}$. An affinity-matured variant achieves a ten-fold improvement in equilibrium dissociation constant, $K_{D,\\mathrm{aff}} = \\dfrac{K_{D,\\mathrm{par}}}{10}$, without altering any other property. Using your derived expression, compute the receptor occupancy for the parental and affinity-matured mAbs and determine the fold-change in occupancy, defined as $\\dfrac{\\theta_{\\mathrm{aff}}}{\\theta_{\\mathrm{par}}}$, at the fixed $[L]$.\n\nReport only the fold-change as a dimensionless decimal number and round your answer to four significant figures. Do not use a percentage sign.", "solution": "The problem statement has been evaluated and is deemed valid. It is scientifically grounded, well-posed, and contains all necessary information for a unique solution. It describes a standard model of monovalent receptor-ligand binding at equilibrium, which is fundamental to pharmacology and immunology.\n\nThe task is twofold: first, to derive an expression for receptor occupancy, $\\theta$, as a function of free ligand concentration, $[L]$, and the equilibrium dissociation constant, $K_{D}$; second, to apply this expression to calculate the fold-change in occupancy for a parental monoclonal antibody (mAb) and its affinity-matured variant.\n\nThe provided definitions are:\n$1$. The equilibrium dissociation constant: $K_{D} = \\dfrac{[R][L]}{[RL]}$\n$2$. The total receptor concentration: $R_{T} = [R] + [RL]$\n$3$. The receptor occupancy: $\\theta = \\dfrac{[RL]}{R_{T}}$\n\nThe goal is to find an expression for $\\theta$ in terms of only $[L]$ and $K_{D}$. We begin by rearranging the definition of $R_{T}$ to express the free receptor concentration, $[R]$, in terms of $R_{T}$ and the complex concentration, $[RL]$:\n$$[R] = R_{T} - [RL]$$\nNext, we substitute this expression for $[R]$ into the definition of $K_{D}$:\n$$K_{D} = \\dfrac{(R_{T} - [RL])[L]}{[RL]}$$\nTo solve for $\\theta$, which is the ratio $\\dfrac{[RL]}{R_{T}}$, we must manipulate this equation algebraically.\n$$K_{D} [RL] = (R_{T} - [RL])[L]$$\n$$K_{D} [RL] = R_{T}[L] - [RL][L]$$\nWe collect all terms containing $[RL]$ on one side of the equation:\n$$K_{D} [RL] + [RL][L] = R_{T}[L]$$\n$$[RL](K_{D} + [L]) = R_{T}[L]$$\nFinally, we divide both sides by $R_{T}$ and by the term $(K_{D} + [L])$ to isolate the ratio $\\dfrac{[RL]}{R_{T}}$:\n$$\\dfrac{[RL]}{R_{T}} = \\dfrac{[L]}{K_{D} + [L]}$$\nBy definition, $\\theta = \\dfrac{[RL]}{R_{T}}$, so we arrive at the required expression for receptor occupancy:\n$$\\theta = \\dfrac{[L]}{K_{D} + [L]}$$\nThis equation is a specific case of the Hill-Langmuir equation for noncooperative binding.\n\nNow, we apply this derived expression to the scenario provided. The given values are:\n- Free ligand concentration: $[L] = 3.00\\,\\mathrm{nM}$\n- Parental mAb dissociation constant: $K_{D,\\mathrm{par}} = 30.0\\,\\mathrm{nM}$\n- Affinity-matured mAb dissociation constant: $K_{D,\\mathrm{aff}} = \\dfrac{K_{D,\\mathrm{par}}}{10} = \\dfrac{30.0\\,\\mathrm{nM}}{10} = 3.00\\,\\mathrm{nM}$\n\nThe receptor occupancy for the parental mAb, $\\theta_{\\mathrm{par}}$, is:\n$$\\theta_{\\mathrm{par}} = \\dfrac{[L]}{K_{D,\\mathrm{par}} + [L]}$$\nThe receptor occupancy for the affinity-matured mAb, $\\theta_{\\mathrm{aff}}$, is:\n$$\\theta_{\\mathrm{aff}} = \\dfrac{[L]}{K_{D,\\mathrm{aff}} + [L]}$$\nWe are asked to compute the fold-change in occupancy, defined as the ratio $\\dfrac{\\theta_{\\mathrm{aff}}}{\\theta_{\\mathrm{par}}}$.\n$$\\text{Fold-change} = \\dfrac{\\theta_{\\mathrm{aff}}}{\\theta_{\\mathrm{par}}} = \\dfrac{\\dfrac{[L]}{K_{D,\\mathrm{aff}} + [L]}}{\\dfrac{[L]}{K_{D,\\mathrm{par}} + [L]}}$$\nThe term $[L]$ in the numerator cancels, and the expression simplifies to:\n$$\\text{Fold-change} = \\dfrac{K_{D,\\mathrm{par}} + [L]}{K_{D,\\mathrm{aff}} + [L]}$$\nSubstituting the numerical values into this expression (note that the units, nM, are consistent and will cancel, yielding a dimensionless result):\n$$\\text{Fold-change} = \\dfrac{30.0 + 3.00}{3.00 + 3.00} = \\dfrac{33.0}{6.00}$$\nPerforming the division:\n$$\\text{Fold-change} = 5.5$$\nThe problem requires the answer to be rounded to four significant figures. The exact value $5.5$ is written as $5.500$ to meet this requirement.", "answer": "$$\\boxed{5.500}$$", "id": "2900130"}, {"introduction": "Beyond high-affinity binding, a successful therapeutic antibody must be a stable and manufacturable drug product. This practice explores the critical concept of protein thermal stability, a key indicator of an antibody's structural integrity and propensity to aggregate. You will learn to interpret data from Differential Scanning Fluorimetry (DSF), a common biophysical technique, to determine the melting temperatures ($T_m$) of an antibody's constituent domains and then use these insights to rationally design a stabilizing formulation. [@problem_id:2900095]", "problem": "A human immunoglobulin G1 (IgG1) therapeutic monoclonal antibody is analyzed by Differential Scanning Fluorimetry (DSF) with a hydrophobic dye to estimate the thermal unfolding midpoints of its three structural regions: the constant heavy chain 2 domain (CH2), the constant heavy chain 3 domain (CH3), and the antigen-binding fragment (Fab). For each domain, a domain-isolated construct is measured to yield a monotonic fluorescence signal versus temperature that can be modeled over the temperature range $30$ to $95$ degrees Celsius by a smooth baseline-plus-sigmoid function. Assume a two-state unfolding model in which the DSF signal is proportional to the unfolded fraction plus a linear baseline. Under this model, the melting temperature $T_m$ is the temperature at which the folded and unfolded populations are equal, which coincides with the inflection point of the sigmoidal transition and the maximum of the first temperature derivative of the signal.\n\nYou are given the following domain-specific DSF signal models as functions of temperature $T$ (in degrees Celsius):\n- CH2: $S_{\\mathrm{CH2}}(T) = 200 + \\dfrac{800}{1 + \\exp\\!\\big(-(T - 64.8)/1.7\\big)} + 0.25\\,T$.\n- CH3: $S_{\\mathrm{CH3}}(T) = 220 + \\dfrac{700}{1 + \\exp\\!\\big(-(T - 72.9)/1.4\\big)} + 0.22\\,T$.\n- Fab: $S_{\\mathrm{Fab}}(T) = 210 + \\dfrac{900}{1 + \\exp\\!\\big(-(T - 68.5)/1.6\\big)} + 0.24\\,T$.\n\nPart A. Using only fundamental definitions of $T_m$ for a two-state thermal transition and calculus applied to the given functions, determine the melting temperatures $T_{m,\\mathrm{CH2}}$, $T_{m,\\mathrm{CH3}}$, and $T_{m,\\mathrm{Fab}}$ as the temperatures that maximize the first derivatives $\\dfrac{dS_{\\mathrm{CH2}}}{dT}$, $\\dfrac{dS_{\\mathrm{CH3}}}{dT}$, and $\\dfrac{dS_{\\mathrm{Fab}}}{dT}$, respectively.\n\nPart B. You now have access to three formulation excipients with empirically calibrated linear contributions to $T_m$ shifts that are approximately additive at low to moderate concentrations. For domain $i \\in \\{\\mathrm{CH2}, \\mathrm{CH3}, \\mathrm{Fab}\\}$ and excipient $j$, the shift obeys $\\Delta T_{m,i} = \\sum_{j} \\alpha_{i,j}\\,c_j$, where $c_j$ is the molar concentration of excipient $j$ and $\\alpha_{i,j}$ is the slope in degrees Celsius per molar. The available excipients, their maximal allowed concentrations, and their domain-specific slopes are:\n- Sucrose: $c_{\\mathrm{Suc}} \\leq 0.40$ $\\mathrm{M}$, with $\\alpha_{\\mathrm{CH2,Suc}} = 2.2$, $\\alpha_{\\mathrm{CH3,Suc}} = 1.6$, $\\alpha_{\\mathrm{Fab,Suc}} = 2.6$.\n- Sodium chloride: $c_{\\mathrm{NaCl}} \\leq 0.15$ $\\mathrm{M}$, with $\\alpha_{\\mathrm{CH2,NaCl}} = 0.6$, $\\alpha_{\\mathrm{CH3,NaCl}} = 0.2$, $\\alpha_{\\mathrm{Fab,NaCl}} = 0.4$.\n- L-arginine hydrochloride: $c_{\\mathrm{Arg}} \\leq 0.25$ $\\mathrm{M}$, with $\\alpha_{\\mathrm{CH2,Arg}} = -0.5$, $\\alpha_{\\mathrm{CH3,Arg}} = -1.2$, $\\alpha_{\\mathrm{Fab,Arg}} = -0.8$.\n\nBased on biophysical first principles of preferential exclusion and ionic shielding in protein stabilization, select the subset of excipients and concentrations (within the given maxima) that strictly increase $T_m$ for all three domains simultaneously. Using your Part A $T_m$ values as baselines, compute the predicted stabilized melting temperatures for CH2, CH3, and Fab under the use of the maximal allowed concentrations of the selected stabilizers.\n\nReport the three stabilized melting temperatures as a row matrix $\\big(T_{m,\\mathrm{CH2}}^{\\mathrm{stab}},\\,T_{m,\\mathrm{CH3}}^{\\mathrm{stab}},\\,T_{m,\\mathrm{Fab}}^{\\mathrm{stab}}\\big)$, rounded to three significant figures. Express temperatures in degrees Celsius. The final answer must be only the row matrix.", "solution": "The problem as stated is scientifically sound, well-posed, and self-contained. It is a valid exercise in applied calculus and biophysical modeling. We proceed with the solution in two parts.\n\nPart A: Determination of Baseline Melting Temperatures ($T_m$)\n\nThe problem defines the melting temperature $T_m$ as the temperature at which the first derivative of the signal function $S(T)$ with respect to temperature $T$ is maximized. This corresponds to the inflection point of the sigmoidal transition. The signal functions provided are of the general form:\n$$S(T) = A + \\frac{L}{1 + \\exp\\left(-\\frac{T - T_0}{k}\\right)} + m T$$\nwhere $A$ is a baseline offset, $L$ is the amplitude of the sigmoid, $T_0$ is the midpoint of the transition, $k$ is related to the steepness of the transition, and $m T$ is a linear baseline drift.\n\nTo find the temperature that maximizes the first derivative, we must find the second derivative and set it to zero.\nFirst, we compute the first derivative, $\\dfrac{dS}{dT}$:\n$$ \\frac{dS}{dT} = \\frac{d}{dT} \\left( A + L \\left(1 + \\exp\\left(-\\frac{T - T_0}{k}\\right)\\right)^{-1} + m T \\right) $$\nApplying the chain rule, we find:\n$$ \\frac{dS}{dT} = L \\cdot \\left(-1\\right) \\left(1 + \\exp\\left(-\\frac{T - T_0}{k}\\right)\\right)^{-2} \\cdot \\exp\\left(-\\frac{T - T_0}{k}\\right) \\cdot \\left(-\\frac{1}{k}\\right) + m $$\n$$ \\frac{dS}{dT} = \\frac{L}{k} \\frac{\\exp\\left(-\\frac{T - T_0}{k}\\right)}{\\left(1 + \\exp\\left(-\\frac{T - T_0}{k}\\right)\\right)^2} + m $$\nThe linear term $m T$ only contributes a constant $m$ to the first derivative and thus does not affect the location of its maximum.\n\nNext, we compute the second derivative, $\\dfrac{d^2S}{dT^2}$, and set it to zero. Let $u = \\exp\\left(-\\frac{T - T_0}{k}\\right)$. Then $\\dfrac{du}{dT} = -\\dfrac{u}{k}$.\n$$ \\frac{d^2S}{dT^2} = \\frac{d}{dT} \\left( \\frac{L}{k} \\frac{u}{(1+u)^2} + m \\right) = \\frac{L}{k} \\frac{d}{dT} \\left( \\frac{u}{(1+u)^2} \\right) $$\nUsing the quotient rule:\n$$ \\frac{d^2S}{dT^2} = \\frac{L}{k} \\left[ \\frac{\\frac{du}{dT}(1+u)^2 - u \\cdot 2(1+u)\\frac{du}{dT}}{(1+u)^4} \\right] = \\frac{L}{k} \\frac{\\frac{du}{dT}(1+u) - 2u\\frac{du}{dT}}{(1+u)^3} $$\nSubstituting $\\dfrac{du}{dT} = -\\dfrac{u}{k}$:\n$$ \\frac{d^2S}{dT^2} = \\frac{L}{k} \\frac{-\\frac{u}{k}(1+u) - 2u(-\\frac{u}{k})}{(1+u)^3} = -\\frac{L}{k^2} \\frac{u(1+u) - 2u^2}{(1+u)^3} = -\\frac{L}{k^2} \\frac{u+u^2-2u^2}{(1+u)^3} = -\\frac{L}{k^2} \\frac{u-u^2}{(1+u)^3} $$\nSetting the second derivative to zero to find the extremum of the first derivative:\n$$ -\\frac{L}{k^2} \\frac{u(1-u)}{(1+u)^3} = 0 $$\nSince $L > 0$, $k > 0$, and $u > 0$, the equation is satisfied only if $1-u=0$, which implies $u=1$.\nSubstituting back $u = \\exp\\left(-\\frac{T - T_0}{k}\\right)$:\n$$ \\exp\\left(-\\frac{T - T_0}{k}\\right) = 1 $$\nTaking the natural logarithm of both sides gives:\n$$ -\\frac{T - T_0}{k} = \\ln(1) = 0 \\implies T = T_0 $$\nThis confirms that the melting temperature $T_m$ is identical to the parameter $T_0$ in the sigmoidal function. We can therefore directly extract the baseline $T_m$ values from the provided signal functions:\n- For CH2: $S_{\\mathrm{CH2}}(T) = 200 + \\dfrac{800}{1 + \\exp\\!\\big(-(T - 64.8)/1.7\\big)} + 0.25\\,T$. Thus, $T_{m,\\mathrm{CH2}} = 64.8\\,^{\\circ}\\mathrm{C}$.\n- For CH3: $S_{\\mathrm{CH3}}(T) = 220 + \\dfrac{700}{1 + \\exp\\!\\big(-(T - 72.9)/1.4\\big)} + 0.22\\,T$. Thus, $T_{m,\\mathrm{CH3}} = 72.9\\,^{\\circ}\\mathrm{C}$.\n- For Fab: $S_{\\mathrm{Fab}}(T) = 210 + \\dfrac{900}{1 + \\exp\\!\\big(-(T - 68.5)/1.6\\big)} + 0.24\\,T$. Thus, $T_{m,\\mathrm{Fab}} = 68.5\\,^{\\circ}\\mathrm{C}$.\n\nPart B: Calculation of Stabilized Melting Temperatures\n\nThe objective is to select excipients that \"strictly increase $T_m$ for all three domains simultaneously.\" This requires that the slope parameter $\\alpha_{i,j}$ be positive for the chosen excipient $j$ across all domains $i \\in \\{\\mathrm{CH2}, \\mathrm{CH3}, \\mathrm{Fab}\\}$. We evaluate the given excipients:\n- Sucrose: $\\alpha_{\\mathrm{CH2,Suc}} = 2.2 > 0$, $\\alpha_{\\mathrm{CH3,Suc}} = 1.6 > 0$, $\\alpha_{\\mathrm{Fab,Suc}} = 2.6 > 0$. All slopes are positive. Sucrose is selected.\n- Sodium chloride: $\\alpha_{\\mathrm{CH2,NaCl}} = 0.6 > 0$, $\\alpha_{\\mathrm{CH3,NaCl}} = 0.2 > 0$, $\\alpha_{\\mathrm{Fab,NaCl}} = 0.4 > 0$. All slopes are positive. Sodium chloride is selected.\n- L-arginine hydrochloride: $\\alpha_{\\mathrm{CH2,Arg}} = -0.5 < 0$, $\\alpha_{\\mathrm{CH3,Arg}} = -1.2 < 0$, $\\alpha_{\\mathrm{Fab,Arg}} = -0.8 < 0$. All slopes are negative. L-arginine is a destabilizer and is rejected.\n\nThe formulation will thus contain Sucrose and Sodium Chloride at their maximal allowed concentrations: $c_{\\mathrm{Suc}} = 0.40\\,\\mathrm{M}$ and $c_{\\mathrm{NaCl}} = 0.15\\,\\mathrm{M}$.\n\nThe total shift in melting temperature, $\\Delta T_{m,i}$, for each domain is calculated using the additive model: $\\Delta T_{m,i} = \\sum_{j} \\alpha_{i,j}\\,c_j$.\n- For CH2:\n$$ \\Delta T_{m,\\mathrm{CH2}} = (\\alpha_{\\mathrm{CH2,Suc}} \\cdot c_{\\mathrm{Suc}}) + (\\alpha_{\\mathrm{CH2,NaCl}} \\cdot c_{\\mathrm{NaCl}}) = (2.2)(0.40) + (0.6)(0.15) = 0.88 + 0.09 = 0.97\\,^{\\circ}\\mathrm{C} $$\n- For CH3:\n$$ \\Delta T_{m,\\mathrm{CH3}} = (\\alpha_{\\mathrm{CH3,Suc}} \\cdot c_{\\mathrm{Suc}}) + (\\alpha_{\\mathrm{CH3,NaCl}} \\cdot c_{\\mathrm{NaCl}}) = (1.6)(0.40) + (0.2)(0.15) = 0.64 + 0.03 = 0.67\\,^{\\circ}\\mathrm{C} $$\n- For Fab:\n$$ \\Delta T_{m,\\mathrm{Fab}} = (\\alpha_{\\mathrm{Fab,Suc}} \\cdot c_{\\mathrm{Suc}}) + (\\alpha_{\\mathrm{Fab,NaCl}} \\cdot c_{\\mathrm{NaCl}}) = (2.6)(0.40) + (0.4)(0.15) = 1.04 + 0.06 = 1.10\\,^{\\circ}\\mathrm{C} $$\n\nThe stabilized melting temperatures, $T_{m,i}^{\\mathrm{stab}}$, are found by adding these shifts to the baseline values from Part A: $T_{m,i}^{\\mathrm{stab}} = T_{m,i} + \\Delta T_{m,i}$.\n- $T_{m,\\mathrm{CH2}}^{\\mathrm{stab}} = 64.8 + 0.97 = 65.77\\,^{\\circ}\\mathrm{C}$\n- $T_{m,\\mathrm{CH3}}^{\\mathrm{stab}} = 72.9 + 0.67 = 73.57\\,^{\\circ}\\mathrm{C}$\n- $T_{m,\\mathrm{Fab}}^{\\mathrm{stab}} = 68.5 + 1.10 = 69.60\\,^{\\circ}\\mathrm{C}$\n\nThe problem requires reporting these values rounded to three significant figures.\n- $T_{m,\\mathrm{CH2}}^{\\mathrm{stab}} \\approx 65.8\\,^{\\circ}\\mathrm{C}$\n- $T_{m,\\mathrm{CH3}}^{\\mathrm{stab}} \\approx 73.6\\,^{\\circ}\\mathrm{C}$\n- $T_{m,\\mathrm{Fab}}^{\\mathrm{stab}} \\approx 69.6\\,^{\\circ}\\mathrm{C}$\n\nThese values form the final answer.", "answer": "$$\n\\boxed{\n\\begin{pmatrix}\n65.8 & 73.6 & 69.6\n\\end{pmatrix}\n}\n$$", "id": "2900095"}, {"introduction": "A high-affinity, stable antibody is not guaranteed to succeed in vivo, especially in the context of solid tumors where physical barriers can severely limit drug delivery. This advanced problem confronts the \"binding-site barrier,\" a phenomenon where the antibody's own high-affinity binding to target antigens near blood vessels can paradoxically hinder its penetration deeper into the tumor mass. By integrating principles of diffusion, mass-action kinetics, and cellular uptake, you will derive a model to predict the characteristic penetration depth and gain a quantitative appreciation for a major challenge in cancer immunotherapy. [@problem_id:2900104]", "problem": "A human Immunoglobulin G (IgG) monoclonal antibody is administered intravenously and supplied to a solid tumor interstitium from a planar capillary surface at position $x=0$. The tumor tissue can be modeled as a homogeneous, isotropic, semi-infinite medium for $x \\ge 0$. The antibody diffuses through the interstitial space and binds to a uniformly distributed cell-surface antigen, after which the antibody–antigen complex is internalized and removed from the interstitium. Assume that the interstitial free antibody concentration is $C(x,t)$ (in $\\mathrm{M}$), the free antigen concentration is $A_{\\mathrm{f}}$ (in $\\mathrm{M}$), and the bound complex concentration is $B(x,t)$ (in $\\mathrm{M}$). The antibody–antigen interaction follows mass-action kinetics with association rate constant $k_{\\mathrm{on}}$ (in $\\mathrm{M^{-1}\\,s^{-1}}$) and dissociation rate constant $k_{\\mathrm{off}}$ (in $\\mathrm{s^{-1}}$). The complex is internalized with first-order rate constant $k_{\\mathrm{int}}$ (in $\\mathrm{s^{-1}}$). Let the antigen total concentration be $A_{\\mathrm{tot}}$ (in $\\mathrm{M}$), with $A_{\\mathrm{tot}} = A_{\\mathrm{f}} + B$. The capillary maintains a constant interstitial boundary concentration $C(0,t) = C_{0}$, and far from the vessel $C(x,t) \\to 0$ as $x \\to \\infty$.\n\nStarting from Fick’s second law and mass-action kinetics, and invoking the quasi-steady-state approximation (QSSA) for the complex $B$ and the low-occupancy limit near the advancing front so that $A_{\\mathrm{f}} \\approx A_{\\mathrm{tot}}$, derive the steady-state spatial profile $C(x)$ and identify the characteristic penetration depth as the distance $L$ at which $C(x)$ falls to $C_{0}/\\exp(1)$.\n\nUse the following physically plausible parameter values:\n- Interstitial diffusion coefficient $D = 3.0 \\times 10^{-7}\\ \\mathrm{cm^{2}\\,s^{-1}}$.\n- Association rate constant $k_{\\mathrm{on}} = 1.0 \\times 10^{5}\\ \\mathrm{M^{-1}\\,s^{-1}}$.\n- Equilibrium dissociation constant $K_{D} = 5.0 \\times 10^{-9}\\ \\mathrm{M}$, with $K_{D} = k_{\\mathrm{off}}/k_{\\mathrm{on}}$.\n- Internalization rate constant $k_{\\mathrm{int}} = 2.0 \\times 10^{-4}\\ \\mathrm{s^{-1}}$.\n- Cell density $n_{\\mathrm{cell}} = 1.0 \\times 10^{8}\\ \\mathrm{cells\\,mL^{-1}}$.\n- Antigen copies per cell $N_{\\mathrm{Ag}} = 2.0 \\times 10^{6}\\ \\mathrm{cell^{-1}}$.\n- Avogadro’s constant $N_{A} = 6.022 \\times 10^{23}\\ \\mathrm{mol^{-1}}$.\n\nTreat the antigen as uniformly distributed over the interstitial volume so that $A_{\\mathrm{tot}}$ is the molar concentration corresponding to the volumetric receptor density computed from $n_{\\mathrm{cell}}$ and $N_{\\mathrm{Ag}}$. Using the derived expression for the penetration depth $L$ and the provided parameters, compute the expected penetration depth and express it in micrometers ($\\mu\\mathrm{m}$). Round your final numerical result to three significant figures. The final answer must be a single number.", "solution": "The problem asks for the derivation of the steady-state spatial profile of a monoclonal antibody concentration in tumor tissue and the calculation of its characteristic penetration depth. The problem is scientifically grounded, well-posed, and contains all necessary information. It is a valid problem in transport phenomena applied to drug delivery.\n\nFirst, we establish the governing partial differential equations for the free antibody concentration, $C(x,t)$, and the bound antibody-antigen complex concentration, $B(x,t)$, based on Fick's second law and mass-action kinetics.\n\nThe equation for the free antibody concentration $C$ includes diffusion and reaction terms (association with free antigen $A_{\\mathrm{f}}$ and dissociation from the complex $B$):\n$$ \\frac{\\partial C}{\\partial t} = D \\frac{\\partial^2 C}{\\partial x^2} - k_{\\mathrm{on}} C A_{\\mathrm{f}} + k_{\\mathrm{off}} B $$\n\nThe equation for the bound complex concentration $B$ includes terms for its formation, dissociation, and internalization:\n$$ \\frac{\\partial B}{\\partial t} = k_{\\mathrm{on}} C A_{\\mathrm{f}} - k_{\\mathrm{off}} B - k_{\\mathrm{int}} B $$\n\nThe total antigen concentration $A_{\\mathrm{tot}}$ is conserved and is the sum of the free antigen $A_{\\mathrm{f}}$ and bound complex $B$:\n$$ A_{\\mathrm{tot}} = A_{\\mathrm{f}} + B $$\n\nThe problem requires the steady-state solution, which implies that all time derivatives are zero: $\\frac{\\partial C}{\\partial t} = 0$ and $\\frac{\\partial B}{\\partial t} = 0$. The equations become a system of ordinary differential equations (ODEs):\n$$ 0 = D \\frac{d^2 C}{d x^2} - k_{\\mathrm{on}} C A_{\\mathrm{f}} + k_{\\mathrm{off}} B \\quad (1) $$\n$$ 0 = k_{\\mathrm{on}} C A_{\\mathrm{f}} - k_{\\mathrm{off}} B - k_{\\mathrm{int}} B \\quad (2) $$\n\nFrom equation $(2)$, we can see that the net rate of antibody consumption by binding, $k_{\\mathrm{on}} C A_{\\mathrm{f}} - k_{\\mathrm{off}} B$, is equal to the rate of internalization, $k_{\\mathrm{int}} B$. Substituting this into equation $(1)$ simplifies the diffusion equation:\n$$ 0 = D \\frac{d^2 C}{d x^2} - k_{\\mathrm{int}} B \\quad (3) $$\n\nThis result demonstrates that at steady-state, the diffusive flux of the antibody is balanced by its removal via internalization of the complex.\n\nNext, we apply the quasi-steady-state approximation (QSSA) for the complex $B$, which is already encompassed by our steady-state condition $\\frac{\\partial B}{\\partial t} = 0$. From equation $(2)$, we solve for $B$:\n$$ B (k_{\\mathrm{off}} + k_{\\mathrm{int}}) = k_{\\mathrm{on}} C A_{\\mathrm{f}} $$\n$$ B = \\frac{k_{\\mathrm{on}} C A_{\\mathrm{f}}}{k_{\\mathrm{off}} + k_{\\mathrm{int}}} $$\n\nWe now invoke the low-occupancy limit approximation, $A_{\\mathrm{f}} \\approx A_{\\mathrm{tot}}$. This is valid near the advancing front of the antibody concentration profile where $C$ is low, and thus the fraction of bound antigen is small. Under this approximation, the expression for $B$ becomes:\n$$ B \\approx \\frac{k_{\\mathrm{on}} A_{\\mathrm{tot}}}{k_{\\mathrm{off}} + k_{\\mathrm{int}}} C $$\n\nSubstituting this expression for $B$ into the simplified diffusion equation $(3)$:\n$$ D \\frac{d^2 C}{d x^2} - k_{\\mathrm{int}} \\left( \\frac{k_{\\mathrm{on}} A_{\\mathrm{tot}}}{k_{\\mathrm{off}} + k_{\\mathrm{int}}} \\right) C = 0 $$\n\nThis is a second-order linear homogeneous ODE. We can write it in the standard form $\\frac{d^2 C}{d x^2} - \\lambda^2 C = 0$, where $\\lambda^2$ is a constant group of parameters:\n$$ \\lambda^2 = \\frac{k_{\\mathrm{int}} k_{\\mathrm{on}} A_{\\mathrm{tot}}}{D (k_{\\mathrm{off}} + k_{\\mathrm{int}})} $$\n\nThe general solution to this ODE is $C(x) = C_1 \\exp(\\lambda x) + C_2 \\exp(-\\lambda x)$. We apply the given boundary conditions:\n1. $C(x) \\to 0$ as $x \\to \\infty$: This requires that the coefficient of the exponentially growing term be zero, so $C_1 = 0$.\n2. $C(0) = C_0$: This determines the remaining coefficient, $C_2 = C_0$.\n\nThe steady-state spatial profile for the antibody concentration is therefore:\n$$ C(x) = C_0 \\exp(-\\lambda x) $$\n\nThe characteristic penetration depth $L$ is defined as the distance at which $C(L) = C_0 / \\exp(1) = C_0 \\exp(-1)$.\n$$ C_0 \\exp(-\\lambda L) = C_0 \\exp(-1) $$\nComparing the exponents, we find $-\\lambda L = -1$, which gives $L = 1/\\lambda$. Thus, the characteristic penetration depth is:\n$$ L = \\sqrt{\\frac{D (k_{\\mathrm{off}} + k_{\\mathrm{int}})}{k_{\\mathrm{int}} k_{\\mathrm{on}} A_{\\mathrm{tot}}}} $$\n\nTo compute the numerical value of $L$, we must first calculate the constants $A_{\\mathrm{tot}}$ and $k_{\\mathrm{off}}$ from the given parameters.\n\nCalculation of total antigen concentration, $A_{\\mathrm{tot}}$:\nThe volumetric density of antigen sites is the product of cell density $n_{\\mathrm{cell}}$ and the number of antigens per cell $N_{\\mathrm{Ag}}$. We must convert units to be consistent.\n$n_{\\mathrm{cell}} = 1.0 \\times 10^{8}\\ \\mathrm{cells\\,mL^{-1}} = 1.0 \\times 10^{8} \\times 10^3\\ \\mathrm{cells\\,L^{-1}} = 1.0 \\times 10^{11}\\ \\mathrm{cells\\,L^{-1}}$.\nThe volumetric density is $(1.0 \\times 10^{11}\\ \\mathrm{cells\\,L^{-1}}) \\times (2.0 \\times 10^{6}\\ \\mathrm{cell^{-1}}) = 2.0 \\times 10^{17}\\ \\mathrm{L^{-1}}$.\nTo convert this to molar concentration, we divide by Avogadro's constant, $N_{A} = 6.022 \\times 10^{23}\\ \\mathrm{mol^{-1}}$.\n$$ A_{\\mathrm{tot}} = \\frac{n_{\\mathrm{cell}} N_{\\mathrm{Ag}}}{N_{A}} = \\frac{(1.0 \\times 10^{11}\\ \\mathrm{L^{-1}}) \\times (2.0 \\times 10^{6})}{6.022 \\times 10^{23}\\ \\mathrm{mol^{-1}}} \\approx 3.321156 \\times 10^{-7}\\ \\mathrm{M} $$\n\nCalculation of the dissociation rate constant, $k_{\\mathrm{off}}$:\nGiven $K_{D} = k_{\\mathrm{off}}/k_{\\mathrm{on}}$.\n$k_{\\mathrm{off}} = K_{D} \\times k_{\\mathrm{on}} = (5.0 \\times 10^{-9}\\ \\mathrm{M}) \\times (1.0 \\times 10^{5}\\ \\mathrm{M^{-1}\\,s^{-1}}) = 5.0 \\times 10^{-4}\\ \\mathrm{s^{-1}}$.\n\nNow we compute $L$. We have the following values:\n$D = 3.0 \\times 10^{-7}\\ \\mathrm{cm^{2}\\,s^{-1}}$\n$k_{\\mathrm{on}} = 1.0 \\times 10^{5}\\ \\mathrm{M^{-1}\\,s^{-1}}$\n$k_{\\mathrm{off}} = 5.0 \\times 10^{-4}\\ \\mathrm{s^{-1}}$\n$k_{\\mathrm{int}} = 2.0 \\times 10^{-4}\\ \\mathrm{s^{-1}}$\n$A_{\\mathrm{tot}} \\approx 3.321156 \\times 10^{-7}\\ \\mathrm{M}$\n\nLet us compute the numerator and denominator for $L^2$ separately.\nNumerator: $D(k_{\\mathrm{off}} + k_{\\mathrm{int}}) = (3.0 \\times 10^{-7}\\ \\mathrm{cm^2\\,s^{-1}}) \\times (5.0 \\times 10^{-4}\\ \\mathrm{s^{-1}} + 2.0 \\times 10^{-4}\\ \\mathrm{s^{-1}})$\n$= (3.0 \\times 10^{-7}) \\times (7.0 \\times 10^{-4})\\ \\mathrm{cm^2\\,s^{-2}} = 2.1 \\times 10^{-10}\\ \\mathrm{cm^2\\,s^{-2}}$.\n\nDenominator: $k_{\\mathrm{int}} k_{\\mathrm{on}} A_{\\mathrm{tot}} = (2.0 \\times 10^{-4}\\ \\mathrm{s^{-1}}) \\times (1.0 \\times 10^{5}\\ \\mathrm{M^{-1}\\,s^{-1}}) \\times (3.321156 \\times 10^{-7}\\ \\mathrm{M})$\n$= (20\\ \\mathrm{M^{-1}\\,s^{-2}}) \\times (3.321156 \\times 10^{-7}\\ \\mathrm{M}) \\approx 6.642312 \\times 10^{-6}\\ \\mathrm{s^{-2}}$.\n\nNow, we compute $L^2$:\n$$ L^2 = \\frac{2.1 \\times 10^{-10}\\ \\mathrm{cm^2\\,s^{-2}}}{6.642312 \\times 10^{-6}\\ \\mathrm{s^{-2}}} \\approx 3.1613 \\times 10^{-5}\\ \\mathrm{cm^2} $$\n$$ L = \\sqrt{3.1613 \\times 10^{-5}}\\ \\mathrm{cm} \\approx 5.6225 \\times 10^{-3}\\ \\mathrm{cm} $$\n\nThe problem requires the answer in micrometers ($\\mu\\mathrm{m}$). Since $1\\ \\mathrm{cm} = 10^4\\ \\mu\\mathrm{m}$:\n$$ L \\approx 5.6225 \\times 10^{-3} \\times 10^4\\ \\mu\\mathrm{m} \\approx 56.225\\ \\mu\\mathrm{m} $$\n\nRounding the result to three significant figures gives $56.2\\ \\mu\\mathrm{m}$.", "answer": "$$\\boxed{56.2}$$", "id": "2900104"}]}